Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Holders of 5% or more of BNTC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Benitec Biopharma Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 13D/A | 44.10%17.8M shares | −5.80 ppfrom 49.90% | Mar 28, 20252 filings | Nov 10, 2025 | SEC |
| Franklin Resources Inc | 13G/A | 14.90%4.14M shares | −1.40 ppfrom 16.30% | Nov 7, 20244 filings | Nov 4, 2025 | SEC |
| Janus Henderson Group PLC | 13G/A | 9.99%3.38M shares | −1.31 ppfrom 11.30% | Feb 14, 20255 filings | Dec 8, 2025 | SEC |
| Ra Capital Management, L.P. | 13G | 5.50%1.85M shares | New | Dec 3, 20251 filing | Dec 3, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
15 Schedule 13D and 13G filings on Benitec Biopharma Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 8, 202511:43 AM ET | Janus Henderson Group PLCand 1 other | 13G/A | 9.99%3.38M shares | −1.31 ppfrom 11.30% | Nov 28, 2025 | SEC |
| Dec 3, 20254:22 PM ET | Ra Capital Management, L.P.and 3 others | 13G | 5.50%1.85M shares | New | Nov 7, 2025 | SEC |
| Nov 10, 20259:53 PM ET | Suvretta Capital Management, LLCand 3 others | 13D/A | 44.10%17.8M shares | −5.80 ppfrom 49.90% | Nov 7, 2025 | SEC |
| Nov 4, 202511:49 AM ET | Franklin Resources Incand 3 others | 13G/A | 14.90%4.14M shares | −1.40 ppfrom 16.30% | Sep 30, 2025 | SEC |
| Aug 14, 202512:23 PM ET | Janus Henderson Group PLCand 1 other | 13G/A | 11.30%2.90M shares | 0.00 ppfrom 11.30% | Jun 30, 2025 | SEC |
| Aug 14, 202511:45 AM ET | Janus Henderson Group PLCand 1 other | 13G/A | 11.30%25.6M shares | −0.10 ppfrom 11.40% | Jun 30, 2025 | SEC |
| May 15, 20254:38 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 4.39%1.04M shares | −5.26 ppfrom 9.65%Below 5% | Mar 31, 2025 | SEC |
| May 14, 202512:49 PM ET | Janus Henderson Group PLCand 1 other | 13G/A | 11.40%2.92M shares | +0.10 ppfrom 11.30% | Mar 31, 2025 | SEC |
| May 9, 20251:06 PM ET | Franklin Resources Incand 3 others | 13G/A | 16.30%4.42M shares | −1.80 ppfrom 18.10% | Mar 31, 2025 | SEC |
| Mar 28, 20254:50 PM ET | Suvretta Capital Management, LLCand 3 others | 13D/A | 49.90%15.6M shares | – | Mar 26, 2025 | SEC |
| Feb 14, 202512:37 PM ET | Janus Henderson Group PLCand 1 other | 13G/A | 11.30%2.62M shares | – | Dec 31, 2024 | SEC |
| Feb 13, 20254:15 PM ET | HBM Healthcare Investments (Cayman) Ltd. | 13G/A | 4.50%1.04M shares | –Below 5% | Dec 31, 2024 | SEC |
| Jan 27, 202512:51 PM ET | Franklin Resources Incand 3 others | 13G/A | 18.10%4.49M shares | +3.00 ppfrom 15.10% | Dec 31, 2024 | SEC |
| Nov 14, 20244:53 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 9.65%1.04M shares | New | Sep 30, 2024 | SEC |
| Nov 7, 202412:30 PM ET | Franklin Resources Incand 3 others | 13G/A | 15.10%4.49M shares | – | Sep 30, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Benitec Biopharma Inc. shares.
No Form 144 notices for Benitec Biopharma Inc. are on file.